InvestorNewsBreaks – Grey Cloak Tech Inc. (GRCK) Subsidiary Enters Strategic Agreement with Key Account

December 15, 2020 11:51:35
Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced that its subsidiary BergaMet NA has entered into an exclusive performance-driven agreement with Xymogen(R) to purchase BergaMet’s Citrus Bergamot SuperFruit(TM). According to the update, the agreement has been three years in development, and Xymogen is now selling and distributing proprietary formulations of BergaCor(TM) and BergaCorPlus(TM) to its 20,000- plus medical doctor network. “This partnership with Xymogen exemplifies Bergamet NA’s strategic B2B goal of a continued growth strategy,” said Duke Pitts, president of BergaMet NA. “We are very excited as this agreement provides significant revenue generation and distribution through Xymogen’s national market footprint. Xymogen also sells our recently introduced CLINICAL IMMUNE(TM) and we anticipate introducing new products as they become available.” To view the full press release, visit https://ibn.fm/Hyskp About Grey Cloak Tech Inc.  Grey Cloak Tech (name change pending to Healthy Extracts Inc.), through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”), is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company’s websites: www.HealthyExtractsInc.com, www.GreyCloakTech.com, www.BergametNA.com, www.UBNutrients.com. NOTE TO INVESTORS: The latest news and updates relating to GRCK are available in the company’s newsroom at http://ibn.fm/GRCK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.